Results for:(61 found)
Mon 2:31 PM on Top StocksBy MSN Money Partner

Shares spike 44% after company gets the green light to file for approval of its experimental drug for Duchenne muscular dystrophy.

Tags: GSKSRPT
Apr 7, 2014 4:24PM on Top StocksBy StreetAuthority

Spending in this area is expected to quadruple by 2025. Here are the best picks to profit from this trend.

Feb 4, 2014 4:27PM on Top StocksBy MSN Money Partner

Instead of racing against each other, the companies are banding together to fight diabetes, arthritis and Alzheimer's.

Nov 29, 2013 11:14AM on Top StocksBy MoneyShow.com

This global pharmaceutical giant continues to buy back shares and boost dividends.

Nov 8, 2013 10:34AM on Top StocksBy TheStreet.com Staff

With close to $20 billion in cash on the balance sheet, Merck is one key acquisition away from turning its fortunes around.

Nov 4, 2013 10:27AM on Top StocksBy TheStreet.com Staff

The drug giant calms worries about its ability to innovate following its spinoff of Zoetis earlier this year.

Sep 19, 2013 10:31AM on Top StocksBy Benzinga

Biotechnology, managed care and pharmaceuticals stocks have soared this year, helping some familiar and overlooked health care ETFs deliver stellar returns.

Sep 16, 2013 11:57AM on Top StocksBy MSN Money Partner

Under Armour is downgraded to 'neutral,' and Bristol-Myers is upgraded to 'overweight.'

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.